Related Experiment Video
Updated: Aug 9, 2026
Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
Published on: January 24, 2025
Retrospective analysis of adult patients with cutaneous leukocytoclastic vasculitis
Yee J Tai1, Alvin H Chong, Richard A Williams
1Department of Dermatology, St. Vincent's Hospital, Melbourne, Victoria, Australia. yeejentai@yahoo.com
Insights
This study on cutaneous leukocytoclastic vasculitis found hypersensitivity vasculitis to be common and often benign. However, excluding systemic involvement and sepsis is crucial for effective patient management.
Area of Science:
- Dermatology
- Rheumatology
- Immunology
Background:
- Cutaneous leukocytoclastic vasculitis (CLV) is an inflammatory condition affecting small blood vessels in the skin.
- Understanding its classification, causes, and outcomes is vital for patient care.
Purpose of the Study:
- To classify, determine aetiology, severity, and prognosis of CLV in 93 adult patients.
- To evaluate a modified classification system based on Chapel Hill Consensus Conference definitions.
Main Methods:
- Retrospective analysis of 93 adult patients diagnosed with CLV.
- Development of a novel classification system for vasculitic syndromes.
Main Results:
- An idiopathic cause was identified in 44.1% of patients; drugs and infections were common causes of secondary vasculitis (40.9%).
- Extracutaneous involvement occurred in 39.8% of patients.
- Hypersensitivity vasculitis was the most frequent classification (15.8% extracutaneous involvement), often benign but requiring exclusion of systemic disease or sepsis.
Conclusions:
- The majority of CLV cases in this cohort were classified as hypersensitivity vasculitis.
- While often benign and skin-limited, careful assessment for systemic involvement and sepsis is essential for appropriate treatment and improved patient outcomes.
Abstract:
A retrospective analysis was conducted on 93 adult patients with cutaneous leukocytoclastic vasculitis from St. Vincent's Hospital Melbourne to determine the classification, aetiology, severity and prognosis of this population of patients. We developed a new classification system for the purposes of our study based on modifications to the Chapel Hill Consensus Conference definitions for vasculitic syndromes. The results of our study indicate that an obvious cause was not found in 44.1% of patients. Of the patients with secondary vasculitis, the commonest causes were drugs and infections, accounting for a total of 40.9% of patients. Extracutaneous involvement was found in 39.8% of patients. Patients with symptoms resolving in less than 3 months accounted for 59.1% of the population, whereas 24.8% of patients had either symptoms lasting three or more months or evidence of recurrent symptomatology. There were 6 deaths (6.91%) and the rest were lost to follow up. The majority of patients in this retrospective series were classified as having hypersensitivity vasculitis, which is a relatively benign disorder limited mostly to skin with a low incidence of extracutaneous involvement (15.8%). Nevertheless, evidence of systemic involvement or sepsis need to be excluded as this may have important implications for patient treatment and outcome.